Breaks Categories: Stock Spotlights

ThursdaySep 19, 2024 2:53 pm

NetworkNewsBreaks – Nightfood Holdings Inc. (NGTF) Evolving into Multifaceted Entity with Diversification Strategy

Nightfood Holdings (OTCQB: NGTF) is actively pursuing diversification and expansion into new and emerging sectors. “Nightfood’s journey began with a simple yet compelling premise: address the growing nighttime snacking epidemic. The company’s flagship products – a line of sleep-friendly cookies – are formulated to minimize sleep disruption caused by unhealthy nighttime snacking and nutritionally support sleep quality… Nightfood isn’t content with simply offering snacks. Recent announcements highlight the company’s acquisition of Future Hospitality Ventures, a provider of automation and robotics technology for the hospitality and foodservice industry… This foray into robotics and AI signifies Nightfood’s ambition to become a solutions…

Continue Reading

WednesdaySep 18, 2024 3:02 pm

NetworkNewsBreaks – SOBR Safe Inc. (NASDAQ: SOBR) Re-Inventing Continuum of Care in Behavioral Health Sector

SOBR Safe (NASDAQ: SOBR) (“SOBRsafe”), the provider of next-generation transdermal alcohol detection solutions, secured 17 customer accounts in the second quarter of 2024, growing its base to 33 new accounts compared to three booked last year. SOBRsafe’s growing list of customers relies on the company’s transdermal technology, which detects and instantaneously reports the presence of alcohol as emitted through a person’s skin. “The new customers have driven SOBRsafe’s revenue up 44% compared to Q2 2023 figures, to $54,191… The recent agreements exemplify the company’s focus on the growing behavioral health market and the progress made since entering this market late…

Continue Reading

WednesdaySep 18, 2024 2:21 pm

NetworkNewsBreaks – Astiva Health Setting New Standard for Healthcare Delivery to Aging Population

Astiva Health is a leading healthcare provider specializing in delivering personalized and comprehensive solutions to diverse communities. The company is launching a comprehensive community outreach initiative to improve wellness and healthcare access for seniors across Southern California. “This initiative represents a significant expansion of Astiva’s commitment to addressing the unique needs of its growing Medicare Advantage Prescription Drug (‘MAPD’) member base. Astiva Health is leveraging its extensive network of local partnerships to bring healthcare services directly into the communities it serves. By collaborating with neighborhood pharmacies, grocery stores and local organizations, Astiva is ensuring that its members can access essential…

Continue Reading

WednesdaySep 18, 2024 1:30 pm

NetworkNewsBreaks – ECGI Holdings Inc. (ECGI) Walking Down Proven Path to Long-Term Success

ECGI (OTC: ECGI), a diversified holding company with a portfolio encompassing viticulture and fashion, is keen on capitalizing on the lucrativeness of luxury fashion. “ECGI Holdings strategically invested in Pacific Saddlery Inc., a company that manufactures and sells luxury equestrian tack, apparel and accessories… Together, ECGI Holdings and Pacific Saddlery have launched a ready-to-wear equestrian apparel collection under the Allon brand. This collection is intended to cater to the growing demand for high-quality equestrian apparel, aligning with ECGI Holdings’ strategy to expand its presence into the luxury equestrian sector,” a recent article reads. “With luxury houses continuously demonstrating that the…

Continue Reading

FridaySep 13, 2024 3:30 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyeing Market Potential with Unique Delivery Platform, GLP-1 Program

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently released its fiscal report for the third quarter of the 2024 financial year (“Q3, 2024”). “Of note was growth in cash and marketable securities from $1.5 million during the same period in the 2023 financial year to $8.5 million as of May 31, 2024. The company reduced certain R&D expenditures and experienced other savings,” reads a recent article. “Most importantly, however, were the program updates for initiatives it embarked on for 2024. A highlight of its projects has been its glucagon-like peptide-1 (‘GLP-1’) agonist research program. GLP-1, a class of drugs, has demonstrated an…

Continue Reading

FridaySep 13, 2024 2:24 pm

NetworkNewsBreaks – Torr Metals Inc. (TSX.V: TMET) Stands Out as Beacon of Opportunity in the Mining Sector

Torr Metals Inc.’s (TSX.V: TMET) Kolos Copper-Gold Project in British Columbia’s Quesnel Trough, a region pulsing with mining history and supported by infrastructure that keeps costs slow and operations running year-round, is strategically positioned. “And it doesn’t stop there. Torr’s Filion Project in northern Ontario sits right off the Trans-Canada Highway, with rail and power infrastructure at its doorstep, making it a prime potential target for the next big gold discovery. Then there’s the Latham Project, anchored in BC’s legendary ‘Golden Triangle,’ an area so rich in minerals that even the highways – like Highway 37 transecting the project, currently…

Continue Reading

FridaySep 13, 2024 1:34 pm

NetworkNewsBreaks – Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Looking to Unlock Significant Potential at Albert Lake, Gochager Lake Properties

Fathom Nickel (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) is a Canadian junior mining exploration and development company focused on acquiring, exploring, and developing high-quality nickel, copper and cobalt deposits. The company is actively exploring the Albert Lake and Gochager Lake properties. “Fathom Nickel’s Albert Lake property is a promising exploration target. Formerly home to the high-grade Rottenstone Mine, this expansive landholding offers significant potential for magmatic nickel sulfide mineralization. Through the addition of the Tremblay-Olson Claims in 2022, the 100%-owned property now encompasses over 90,000 hectares. Fathom’s ongoing exploration works aim to unlock the full potential of this historically productive…

Continue Reading

ThursdaySep 12, 2024 2:07 pm

NetworkNewsBreaks – ECGI Holdings Inc. (ECGI) Poised for Growth Across Luxury Equestrian Segments

ECGI (OTC: ECGI), a diversified holding company, is targeting a share of the growing luxury goods market by designing, manufacturing and selling equestrian apparel and equipment through its subsidiary Pacific Saddlery. “ECGI recognizes that a marginal share of a globally large market would translate to more revenue annually than even a big share of a small market, and sees smaller focused markets as a proven entrance pathway to much larger general luxury markets… Valued at billions of dollars, the luxury equestrian market is segmented into two: the luxury equestrian apparel segment, which covers the design, production and sale of high-end…

Continue Reading

FridayAug 30, 2024 2:45 pm

NetworkNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) BayMedica Poised as Rare Cannabinoids Drive Market Growth

InMed Pharmaceuticals’ (NASDAQ: INM) subsidiary BayMedica is positioned amid a growing interest in edibles infused with non-intoxicating minor cannabinoids. These lesser-known cannabinoids offer unique properties and potential health benefits, driving significant market growth. The company published a report on the expansion of the minor cannabinoid market in 2023. “The report, based on data from Headset, the largest industry dataset, explores the growth, competition and consumer trends in ten regulated states, encompassing 85 million of the 158 million residents in areas where recreational cannabis is legal,” reads a recent article. “The report highlights a 5.4% revenue increase in the edible market,…

Continue Reading

FridayAug 30, 2024 2:24 pm

NetworkNewsBreaks – Clene Inc. (NASDAQ: CLNN) Positioned as Leader in Addressing Neurodegenerative Diseases

Clene (NASDAQ: CLNN), a biopharmaceutical company, is at the forefront of transforming the treatment of neurodegenerative disorders like amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”). “Clene’s lead agent, CNM-Au8, targets the nicotinamide adenine dinucleotide (‘NAD+’) pathway to restore and protect neurological function. CNM-Au8 works by improving cellular energy production and utilization, which is crucial for maintaining neuronal health. Mitochondrial dysfunction is a common pathway leading to neuronal death in neurodegenerative diseases. By targeting this dysfunction, CNM-Au8 aims to provide neuroprotection and promote remyelination, potentially altering the course of these debilitating conditions,” a recent article reads. “Clene has conducted extensive…

Continue Reading